Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07505771 · ClinicalTrials.gov registry record · Early Phase 1
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
A Early Phase 1 study, sponsored by Immunome.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 105
- Enrollment target
NCT07505771: Recruiting Early Phase 1 study, sponsored by Immunome.
NCT07505771 is a Early Phase 1 study that is actively recruiting participants, run by Immunome. The registered enrollment target is 105 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07505771, a Early Phase 1 study, is actively recruiting participants, sponsored by Immunome.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 105 participants
- Enrollment target
Study Summary
IM-3050-101 is a Phase 1 study to determine the safety and effectiveness of 177Lu-IM-3050 in treating participants with advanced cancer.
Primary Outcome
Type, frequency, seriousness, and severity of adverse events (AEs) graded using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) criteria version 6.0, including adverse events (SAEs), AEs leading to discontinuation, and deaths
Interventions
- DRUG 177Lu-IM-3050
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2026-06 |
| Est. Completion | 2034-12 |
| Phase | Early Phase 1 |
What NCT07505771 shows while recruiting
NCT07505771 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% higher).
The record links to 0 conditions, and to 1 intervention - of which 177Lu-IM-3050 is the first listed.
NCT07505771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07505771 about?
NCT07505771 is a clinical study titled "A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer". IM-3050-101 is a Phase 1 study to determine the safety and effectiveness of 177Lu-IM-3050 in treating participants with advanced cancer.
What is the current status of trial NCT07505771?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 105 participants. The study started on 2026-06. Estimated completion is 2034-12.
What interventions are being tested in trial NCT07505771?
The interventions under investigation include: 177Lu-IM-3050 (DRUG).
Who is sponsoring clinical trial NCT07505771?
This trial is sponsored by Immunome, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07505771's enrollment target sits among peer trials
105 175th of 2000 higher than 1,826 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia